<DOC>
	<DOCNO>NCT00850278</DOCNO>
	<brief_summary>The primary objective study assess efficacy radiopharmaceutical 3'-deoxy-3'- [ F-18 ] fluorothymidine , [ F-18 ] FLT , tracor cell proliferation , use Positron Emission Tomography ( PET ) image tumor diagnosis prognosis group 50 patient different type brain tumor . [ F-18 ] FLT PET image compare current use imaging technique MRI , spectroscopy imaging , PET image use [ 11C ] MET tracer , immunohistochemical analysis clinical parameter .</brief_summary>
	<brief_title>Assessment 18FFLT-PET Imaging Diagnosis Prognosis Brain Tumors</brief_title>
	<detailed_description />
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>adult age 18 70 year must operable grade II , III IV glioma , recurrent high grade glioma brain metastasis KPS &gt; = 70 % must understand ability sign inform consent document must adequate liver kidney function male nonpregnant , nonlactating female patient fertile must agree use effective method contraception participation study follow laboratory result : absolute neutrophil count &gt; = 1500 cells/µl , platelet count &gt; = 100000 cells/µl , SGOT &lt; = 2.5 x ULN , serum creatinine &lt; = 1.5 x ULN . contraindication surgery concomitant radio , chemo , immunotherapy history significant dementia know diagnosis Human Immunodeficiency Virus ( HIV ) infection patient hepatitis B C</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Brain tumor</keyword>
	<keyword>[ 18F ] FLT</keyword>
	<keyword>[ 11C ] MET</keyword>
	<keyword>TEP-imaging</keyword>
	<keyword>tumor cell proliferation</keyword>
</DOC>